Heterogeneity in resistance mechanisms causes shorter duration of epidermal growth factor receptor kinase inhibitor treatment in lung cancer
2014 ◽
Vol 21
(S4)
◽
pp. 610-618
◽
2016 ◽
Vol 24
(5)
◽
pp. 263-279
◽
2012 ◽
Vol 31
(3-4)
◽
pp. 807-814
◽
1986 ◽
Vol 39
(2)
◽
pp. 314-315
◽
1986 ◽
Vol 39
(1)
◽
pp. 170-173
◽